CPD-2828 is an orally active and selective IRE1alpha inhibitor with an IC50 value of 1.2 µM. CPD-2828 is promising for research of endoplasmic reticulum stress-related diseases (e.g., cancer, neurodegenerative diseases)[1].
Molecular Weight:
531.56
Formula:
C29H29N3O7
Target:
IRE1
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
